Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 602, Issue 1-2, 2006, Pages 143-150

  Shao, Lina ^a   Hittelman, Walter N ^a   Lin, Jie ^a   Yang, Hushan ^a   Ajani, Jaffer A ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell cycle checkpoint; DNA damage and repair; Esophageal cancer risk

Indexed keywords

BENZO(A)PYRENE DIOL EPOXIDE; BENZOIC ACID DERIVATIVE; DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; COMET ASSAY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ESOPHAGUS CANCER; FEMALE; FLOW CYTOMETRY; GAMMA RADIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MUTAGENIC ACTIVITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; STATISTICAL SIGNIFICANCE;

AGED; BENZOPYRANS; CELL CYCLE; DNA DAMAGE; DNA REPAIR; EPOXY COMPOUNDS; ESOPHAGEAL NEOPLASMS; FEMALE; GAMMA RAYS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTAGENS;

EID: 33750616890     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.08.011     Document Type: Article

References (34)

1. Cancer facts and Figures 2006 (2006), American Cancer Society, Altanta
2. Blot W.J., Devesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 (1991) 1287-1289
3. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
4. Vizcaino A.P., Moreno V., Lambert R., and Parkin D.M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int. J. Cancer 99 (2002) 860-868
5. Koch T.R. The changing face of esophageal malignancy. Curr. Gastroenterol. Rep. 5 (2003) 187-191
6. Wu A.H., Wan P., and Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12 (2001) 721-732
7. Enzinger P.C., and Mayer R.J. Esophageal cancer. N. Engl. J. Med. 349 (2003) 2241-2252
8. Wei J.T., and Shaheen N. The changing epidemiology of esophageal adenocarcinoma. Semin. Gastrointest. Dis. 14 (2003) 112-127
9. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
10. Ferguson D.O., Sekiguchi J.M., Frank K.M., Gao Y., Sharpless N.E., Gu Y., Manis J., DePinho R.A., and Alt F.W. The interplay between nonhomologous end-joining and cell cycle checkpoint factors in development, genomic stability, and tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 65 (2000) 395-403
11. Stucki M., Stagljar I., Jonsson Z.O., and Hubscher U. A coordinated interplay: proteins with multiple functions in DNA replication, DNA repair, cell cycle/checkpoint control, and transcription. Prog. Nucl. Acid. Res. Mol. Biol. 65 (2001) 261-298
12. Giannattasio M., Lazzaro F., Longhese M.P., Plevani P., and Muzi-Falconi M. Physical and functional interactions between nucleotide excision repair and DNA damage checkpoint. Embo. J. 23 (2004) 429-438
13. Decraene D., Agostinis P., Pupe A., de Haes P., and Garmyn M. Acute response of human skin to solar radiation: regulation and function of the p53 protein. J. Photochem. Photobiol. B 63 (2001) 78-83
14. Hartwell L.H., and Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 246 (1989) 629-634
15. Shao L., Lin J., Huang M., Ajani J.A., and Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer 44 (2005) 415-422
16. Wu X., Roth J.A., Zhao H., Luo S., Zheng Y.L., Chiang S., and Spitz M.R. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 65 (2005) 349-357
17. Zhao H., Spitz M.R., Tomlinson G.E., Zhang H., Minna J.D., and Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 61 (2001) 7819-7824
18. W.K. Kaufmann, L. Filatov, S.E. Oglesbee, D.A. Simpson, M.A. Lotano, H.D. McKeen, L.R. Sawyer, D.T. Moore, R.C. Millikan, M. Cordeiro-Stone, and L.A. Carey Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk, Carcinogenesis, 2006 [Epub ahead of print].
19. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
20. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27 (2001) 247-254
21. van Gent D.C., Hoeijmakers J.H., and Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2 (2001) 196-206
22. Iliakis G., Wang Y., Guan J., and Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22 (2003) 5834-5847
23. Paules R.S., Levedakou E.N., Wilson S.J., Innes C.L., Rhodes N., Tlsty T.D., Galloway D.A., Donehower L.A., Tainsky M.A., and Kaufmann W.K. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55 (1995) 1763-1773
24. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 33 (2000) 261-274
25. Zheng Y.L., Loffredo C.A., Alberg A.J., Yu Z., Jones R.T., Perlmutter D., Enewold L., Krasna M.J., Yung R., Shields P.G., and Harris C.C. Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res. 65 (2005) 9566-9573
26. Buchholz T.A., and Wu X. Radiation-induced chromatid breaks as a predictor of breast cancer risk. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 533-537
27. Chang J.Y., Komaki R., Sasaki R., Liao Z., Stevens C.W., Lu C., Fossella F.V., Allen P.K., Cox J.D., Spitz M.R., and Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin. Cancer Res. 11 (2005) 2894-2898
28. Cloos J., Steen I., Timmerman A.J., van der Schans G.P., Snow G.B., and Braakhuis B.J. DNA-damage processing in blood lymphocytes of head-and-neck-squamous-cell-carcinoma patients is dependent on tumor site. Int. J. Cancer 68 (1996) 26-29
29. Shao L., Lai M., and Huang Q. Mutagen sensitivity and p53 expression in colorectal cancer in China. Postgrad. Med. J. 77 (2001) 713-716
30. McKenna W.G., Iliakis G., Weiss M.C., Bernhard E.J., and Muschel R.J. Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125 (1991) 283-287
31. Bernhard E.J., Maity A., Muschel R.J., and McKenna W.G. Effects of ionizing radiation on cell cycle progression. A review. Radiat. Environ. Biophys. 34 (1995) 79-83
32. Larner J.M., Lee H., and Hamlin J.L. S phase damage sensing checkpoints in mammalian cells. Cancer Surv. 29 (1997) 25-45
33. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
34. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31 (1997) 635-662